Novartis (NVS) Tops Q2 EPS by 23c; offers outlook

Novartis (NYSE: NVS) reported Q2 EPS of $2.41, $0.23 better than the analyst estimate of $2.18. Revenue for the quarter came in at $14.41 billion versus the consensus estimate of $14.17 billion.

Outlook

Net sales expected to grow low single-digit (vs. estimated growth of 0.41% Y/Y) and core operating income expected to decline low single-digit.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays